Cancerous and noncancerous tissues from 12 patients with HSCC were examined for the expression of mTOR by using real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) in order to elucidate whether the expression levels of mTOR were altered in cancerous tissues. This evidence concerns the gene MTOR and cancer.